A detailed history of Horizon Kinetics Asset Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Horizon Kinetics Asset Management LLC holds 11,797 shares of NVS stock, worth $1.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,797
Previous 11,797 -0.0%
Holding current value
$1.3 Million
Previous $1.14 Million 9.99%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 15, 2024

SELL
$92.27 - $101.54 $37,184 - $40,920
-403 Reduced 3.3%
11,797 $1.19 Million
Q1 2023

May 12, 2023

SELL
$80.03 - $92.81 $532,199 - $617,186
-6,650 Reduced 35.28%
12,200 $1.12 Million
Q4 2022

Feb 07, 2023

SELL
$75.55 - $92.52 $173,765 - $212,796
-2,300 Reduced 10.87%
18,850 $1.71 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $82,071 - $95,986
1,100 Added 5.49%
21,150 $1.61 Million
Q4 2021

Feb 15, 2022

SELL
$79.7 - $88.13 $70,136 - $77,554
-880 Reduced 4.2%
20,050 $1.75 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $31,076 - $36,153
-380 Reduced 1.78%
20,930 $1.71 Million
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $63,929 - $70,612
-750 Reduced 3.4%
21,310 $1.94 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $97,977 - $118,509
-1,255 Reduced 5.38%
22,060 $2.08 Million
Q3 2020

Nov 16, 2020

BUY
$82.14 - $91.0 $45,998 - $50,960
560 Added 2.46%
23,315 $2.03 Million
Q2 2020

Aug 14, 2020

SELL
$80.93 - $91.1 $166,311 - $187,210
-2,055 Reduced 8.28%
22,755 $1.99 Million
Q1 2020

May 13, 2020

SELL
$70.67 - $99.01 $20,564 - $28,811
-291 Reduced 1.16%
24,810 $2.05 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $2,699 - $3,051
-32 Reduced 0.13%
25,101 $2.38 Million
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $56,550 - $69,600
-750 Reduced 2.9%
25,133 $2.3 Million
Q1 2019

May 15, 2019

BUY
$75.32 - $86.15 $1.95 Million - $2.23 Million
25,883 New
25,883 $2.49 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Horizon Kinetics Asset Management LLC Portfolio

Follow Horizon Kinetics Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Kinetics Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Kinetics Asset Management LLC with notifications on news.